$2.90
-0.03-1.02%
At close: -
$2.89
-0.01000-0.34%
After Hours: 7:22 PM EDT
Comments
Loading...
Latest Alzamend Neuro Stock News | NASDAQ:ALZN | Benzinga
Get the latest news on Alzamend Neuro stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Alzamend Neuro performance
Categories: All
Friday, May 30, 2025
Thursday, May 29, 2025
- Alzamend Neuro (ALZN) Stock Surges On AL001 Phase II Trial Milestone
- Crude Oil Falls Over 1%; Best Buy Reports Downbeat Results
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Nasdaq Gains Over 1%; Nvidia Posts Strong Revenue
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Alzamend Neuro shares are trading higher afte...
- Alzamend Neuro Doses First Patient In Phase I...
Monday, May 19, 2025
Tuesday, May 13, 2025
- ALZN stock has given up its prior gain. Alzam...
- Alzamend Neuro shares are trading higher afte...
- EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants
- EXLCUSIVE: Alzamend Neuro Tells Benzinga 'Hea...
- EXLCUSIVE: Alzamend Neuro Tells Benzinga 'Top...
- EXLCUSIVE: Alzamend Neuro Tells Benzinga Co. ...
